Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Neuroradiology ; 57(12): 1203-9, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26293130

RESUMO

INTRODUCTION: Limbic encephalitis (LE) associated with voltage-gated potassium channel-complex antibodies (VGKC-LE) is frequently non-paraneoplastic and associated with marked improvement following corticosteroid therapy. Mesial temporal lobe abnormalities are present in around 80 % of patients. If associated or preceded by faciobrachial dystonic seizures, basal ganglia signal changes may occur. In some patients, blurring of the supratentorial white matter on T2-weighted images (SWMB) may be seen. The purpose of this study was to evaluate the incidence of SWMB and whether it is specific for VGKC-LE. METHODS: Two experienced neuroradiologists independently evaluated signal abnormalities on FLAIR MRI in 79 patients with LE while unaware on the antibody type. RESULTS: SWMB was independently assessed as present in 10 of 36 (28 %) compared to 2 (5 %) of 43 non-VGKC patients (p = 0.009). It was not related to the presence of LGI1 or CASPR2 proteins of VGKC antibodies. MRI showed increased temporomesial FLAIR signal in 22 (61 %) VGKC compared to 14 (33 %) non-VGKC patients (p = 0.013), and extratemporomesial structures were affected in one VGKC (3 %) compared to 11 (26 %) non-VGKC patients (p = 0.005). CONCLUSION: SWMB is a newly described MRI sign rather specific for VGKC-LE.


Assuntos
Cérebro/patologia , Imagem de Tensor de Difusão/métodos , Encefalite Límbica/imunologia , Encefalite Límbica/patologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/imunologia , Substância Branca/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Autoanticorpos/imunologia , Cérebro/imunologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Substância Branca/imunologia , Adulto Jovem
2.
Nervenarzt ; 86(8): 989-96, 2015 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-25956824

RESUMO

BACKGROUND: Autologous hematopoietic stem cell transplantation (aHSCT) is still not the standard treatment for highly inflammatory multiple sclerosis (MS). Even though randomized controlled trials are lacking, predictors for treatment response have been established. Since 2007, ten patients have received aHSCT in Hamburg. OBJECTIVE: To present observational data from patients treated in Hamburg and a review of the literature. METHODS: Descriptive statistics were used for evaluating the course of the expanded disability status scale (EDSS) as a measure for clinical outcome, magnetic resonance imaging (MRI) and neuropsychology. New gadolinium and T2-MRI uptake lesions per scan were compared. In addition, a systematic review of the currently available literature was performed. RESULTS: The Hamburg series can be divided in two groups, one group including four patients with chronic progressive MS with low inflammatory activity (median EDSS = 6.25, 0.5 relapses per year, no gadolinium-enhancing lesions) and the other group including six patients with mild to moderate disability, relapses and inflammatory activity (median EDSS = 4.25, 1 relapse per year, 2 gadolinium-enhancing lesions). The median follow-up was 2.4 years. While the first group did not seem to benefit from aHSCT, an improvement in five out of six patients was observed in the second group. New T2 lesions occurred within the first 6 months but gadolinium-enhancing lesions were not observed (p < 0.05). A systematic literature search identified a higher efficacy of aHSCT in younger, less disabled MS patients with inflammatory activity, similar to the findings from Hamburg. CONCLUSION: Cohort reports describe aHSCT as a safe and efficient treatment option in highly inflammatory MS. Based on these data aHSCT seems to be a reasonable option in selected patients with highly inflammatory MS but a randomized controlled trial is warranted.


Assuntos
Pesquisa Biomédica/tendências , Esclerose Múltipla/diagnóstico , Esclerose Múltipla/terapia , Regeneração Nervosa , Transplante de Células-Tronco/métodos , Transplante de Células-Tronco/tendências , Adulto , Medicina Baseada em Evidências , Alemanha , Humanos , Internacionalidade , Resultado do Tratamento
3.
Mult Scler ; 19(7): 920-5, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23037548

RESUMO

BACKGROUND: Balancing treatment benefits and risks is part of a shared decision-making process before initiating any treatment in multiple sclerosis (MS). Patients understand, appreciate and profit from evidence-based patient information (EBPI). While these processes are well known, long-term risk awareness and risk processing of patients has not been studied. Mitoxantrone treatment in MS is associated with long-term major potential harms - leukaemia (LK) and cardiotoxicity (CT). The risk knowledge and perception among patients currently or previously treated with mitoxantrone is unknown. OBJECTIVES: The objective of this article is to conduct a retrospective cohort study in greater Hamburg, Germany, to estimate risk awareness and perception in MS patients treated with mitoxantrone. METHODS: MS patients with at least one dose of mitoxantrone between 1991 and 2010 from six major MS centres in greater Hamburg received a questionnaire assessing risk awareness and perception as well as a written EBPI about mitoxantrone-associated LK and CT. RESULTS: Fifty-one per cent in the cohort of n = 575 patients returned the questionnaire. Forty per cent correctly estimated the risk of LK (CT 16%); 56% underestimated the risk (CT 82%). Reading the information increased the accuracy of LK risk estimation, and patients did not report an increase of worries. The EBPI was appreciated and recommended by 85%. CONCLUSION: Risk awareness of mitoxantrone-treated patients is insufficient, but can be increased by EBPI without increasing worries. Continued patient information during and after treatment should be implemented in management algorithms.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Mitoxantrona/efeitos adversos , Esclerose Múltipla Crônica Progressiva/tratamento farmacológico , Inibidores da Topoisomerase II/efeitos adversos , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Risco , Inquéritos e Questionários
5.
Gesundheitswesen ; 61(10): 480-6, 1999 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-10593052

RESUMO

"Environmental medicine" is a new sub-discipline in the spectrum of medical specialization in Germany. The Berlin Academy of Occupational Medicine and Health Protection, now a branch of the Berlin Chamber of Physicians, developed a 200-lesson curriculum for physicians who want to specialize in this field. Coincidentally during the initial courses, the attendants were already highly qualified ("Facharzt"-level) and experts in various occupational fields, and hence the composition of the classes was highly heterogeneous on the levels of practical experience as well as theoretical knowledge. The Academy therefore decided to change the teaching method to Problem-Oriented Learning (POL). This required training tutors for small learning groups, supervision for these tutors and supplying adequate teaching materials and a stimulating environment for the student. The "Arbeitsgruppe Reformstudiengang Medizin" (Medicine Curriculum Reform Project) at the Berlin Humboldt University as well as the Dutch Rijksuniversiteit Limburg in Maastricht helped in the process of conceptualization. Participants worked in groups of up to 8 persons under non-directive tutors. A new "case" was presented every day, and the students developed individual learning goals according to the Seven Steps-method, which were then researched individually and with the help of outside experts. The findings were reported back and discussed in the group. Initially there was irritation, but after two or three days participants got used to not being lectured. Instead of being passive recipients of expert knowledge they felt that the POL method of learning enhanced their competence to act independently.


Assuntos
Medicina Ambiental/educação , Aprendizagem Baseada em Problemas , Currículo , Alemanha , Humanos , Especialização
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa